Skip to content

What is MHT surgery?

4 min read

An estimated 30% of epilepsy patients suffer from drug-resistant seizures, for which surgery may be an option. In this specialized context, the answer to What is MHT surgery? refers to Multiple Hippocampal Transection, a precise neurosurgical procedure that disrupts seizure propagation pathways.

Quick Summary

MHT surgery, or Multiple Hippocampal Transection, is a neurosurgical procedure used to treat drug-resistant temporal lobe epilepsy by making small cuts in the hippocampus to disrupt seizure propagation while preserving memory function.

Key Points

  • Multiple Hippocampal Transection: MHT surgery is a neurosurgical procedure used to treat drug-resistant epilepsy, specifically originating in the hippocampus.

  • Targeted Treatment: Unlike older surgical methods, MHT focuses on disrupting the seizure-spreading pathways in the hippocampus rather than removing the entire tissue.

  • Memory Preservation: By carefully transecting longitudinal fibers while preserving transverse ones, the procedure aims to control seizures with a lower risk of memory loss compared to resective surgery.

  • Not Menopausal Hormone Therapy: The acronym MHT also stands for Menopausal Hormone Therapy, a completely different medical treatment unrelated to surgery.

  • Intraoperative Monitoring: Surgeons use electrocorticography (ECoG) during the surgery to ensure that the transections have effectively stopped the epileptic discharges.

  • Candidacy: This is a specialized treatment for patients who have not responded to medication and whose seizure focus is precisely located in the hippocampus.

In This Article

Deciphering the Medical Acronym: MHT

In the medical world, acronyms can have multiple meanings, leading to confusion. While MHT is commonly known as Menopausal Hormone Therapy, in the specific context of a surgical procedure, it refers to Multiple Hippocampal Transection. This complex neurosurgical technique is a crucial treatment option for individuals with severe, medication-resistant epilepsy originating in the hippocampus. By understanding the full context, patients and families can better navigate treatment options.

The Purpose and Mechanism of Multiple Hippocampal Transection

MHT was developed as a less invasive alternative to a traditional temporal lobectomy, which involves the resection (removal) of a portion of the temporal lobe and hippocampus. The core purpose of MHT is to disrupt the neural pathways responsible for propagating seizures within the hippocampus, thereby controlling or eliminating seizures without the extensive brain tissue removal associated with a full lobectomy.

The mechanism of action is highly targeted. The procedure involves making multiple, precise, transverse cuts (transections) across the longitudinal fibers of the hippocampus. These longitudinal fibers are believed to be the primary pathways for seizure propagation, while the critical vertical fiber tracts responsible for memory function are left intact. This selective disruption aims to achieve seizure control while minimizing the risk of cognitive and memory deficits that can sometimes occur with resective surgery, especially in the dominant hemisphere.

How the Procedure is Performed

The MHT procedure is a specialized neurosurgical operation. Patients undergo extensive pre-operative evaluation, which may include prolonged video-EEG monitoring and brain imaging, to precisely locate the seizure focus within the hippocampus.

  1. Anesthesia: The patient is placed under general anesthesia.
  2. Surgical Access: Surgeons use advanced imaging techniques and sometimes a stereotactic navigation system to gain access to the hippocampus, often through the temporal horn of the brain's lateral ventricle.
  3. Intraoperative Monitoring: Intraoperative electrocorticography (ECoG) is often used during the procedure. Electrodes are placed on the surface of the hippocampus to monitor brain activity and confirm that the transections are effectively stopping the epileptic discharges.
  4. Creating Transections: Using a specialized, blunt-tipped tool, the surgeon creates a series of transverse cuts across the hippocampus. The depth and spacing of the cuts are carefully controlled to interrupt the longitudinal fibers while sparing the vertical ones.
  5. Confirming Efficacy: The ECoG is used to confirm that synchronized epileptiform activity has ceased after the transections are completed. This real-time feedback helps ensure the procedure is adequate for seizure control.
  6. Closure: The surgical site is closed once the intraoperative monitoring confirms the desired effect.

MHT vs. Standard Temporal Lobectomy

While traditional temporal lobectomy has long been the gold standard for treating drug-resistant temporal lobe epilepsy, MHT offers a different approach. The choice between these two surgical options depends on the patient's specific condition, the location of the seizure focus, and an assessment of potential risks.

Feature Multiple Hippocampal Transection (MHT) Temporal Lobectomy
Primary Goal Disrupt seizure propagation pathways. Remove the epileptogenic brain tissue.
Tissue Removal None. Preserves the hippocampus. Resects part of the temporal lobe, including the hippocampus.
Risk to Memory Lower risk of verbal memory impairment, especially in the dominant hemisphere. Higher risk of verbal and nonverbal memory deficits, particularly if the dominant hemisphere is involved.
Seizure Control High rate of seizure freedom in appropriately selected patients. Effective seizure control, long-standing success record.
Complexity Highly specialized, technically demanding neurosurgical procedure. A standard, though still complex, epilepsy surgery.

Who is a Candidate for MHT Surgery?

Candidates for MHT surgery are typically individuals who have a diagnosis of drug-resistant epilepsy, specifically with a seizure focus clearly localized to the hippocampus. This procedure is particularly considered for patients where a standard temporal lobectomy would pose a high risk of significant memory loss, often due to minimal or no sclerosis in the dominant temporal lobe. A comprehensive neuropsychological evaluation is a critical part of determining a patient's suitability for this specialized surgery.

Other Medical Meanings of MHT

To avoid confusion, it is important to clarify that the acronym MHT is also widely used for other medical contexts. These should not be mistaken for the neurosurgical procedure.

  • Menopausal Hormone Therapy (MHT): This is a medical treatment, not a surgery, that involves replacing hormones like estrogen and progesterone to relieve symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness. It was formerly known as Hormone Replacement Therapy (HRT).
  • Magnetic Hyperthermia Therapy (MHT): An experimental treatment for certain cancers, including brain tumors, involving the surgical delivery of magnetic nanoparticles to a tumor. An external alternating magnetic field is then applied to heat the nanoparticles, generating localized heat to kill cancer cells.
  • Maximum Harvesting Technique (MHT): A hair restoration procedure that combines elements of both Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE) to maximize the number of grafts harvested.

For more in-depth information about epilepsy surgical options, you can visit the Defeating Epilepsy Foundation website.

Conclusion

Understanding what is MHT surgery and its specific context as Multiple Hippocampal Transection is vital for patients exploring advanced epilepsy treatments. This innovative neurosurgical technique offers a potential path to seizure freedom while prioritizing the preservation of cognitive function, representing a significant advancement over more traditional, resective procedures. It is a highly specialized option for select candidates who have not responded to standard medical treatments.

Frequently Asked Questions

In the context of epilepsy, MHT surgery stands for Multiple Hippocampal Transection. It is a procedure for treating drug-resistant seizures originating in the hippocampus.

A temporal lobectomy involves removing brain tissue from the temporal lobe, including the hippocampus. MHT surgery, in contrast, disrupts seizure pathways within the hippocampus through targeted cuts while preserving the tissue itself, potentially minimizing cognitive side effects.

MHT surgery is designed to preserve memory function by leaving the transverse (memory-related) neural fibers intact while only cutting the longitudinal (seizure-related) fibers. While any brain surgery carries risks, the goal is to minimize memory impairment compared to a full resection.

Studies have shown that MHT can achieve a high rate of seizure control, with many patients becoming seizure-free, especially when intraoperative monitoring confirms the cessation of epileptic activity.

Ideal candidates for MHT are those with intractable (drug-resistant) epilepsy whose seizures are confined to the hippocampus. They are thoroughly evaluated through pre-surgical testing to confirm the exact location of the seizure focus.

No, they are completely different. While the acronym is the same, Menopausal Hormone Therapy (MHT) is a non-surgical treatment involving hormones for menopause symptoms, while Multiple Hippocampal Transection (MHT) is a neurosurgical procedure for epilepsy.

Recovery from MHT surgery varies, but patients are monitored closely after the procedure. Neurological outcomes, including seizure control and memory, are typically assessed in the months following surgery. Most patients require ongoing medical management of their epilepsy.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.